XML 22 R7.htm IDEA: XBRL DOCUMENT v3.19.1
Consolidated Statements of Stockholders' Equity (Deficit) - USD ($)
$ in Thousands
Common Stock
Additional Paid-In Capital
Accumulated Other Comprehensive Income (Loss)
Retained Earnings
Treasury Stock
Noncontrolling Interests in Subsidiaries
Total
Balance at Dec. 27, 2015 $ 437 $ 158,348 $ (1,836) $ 143,789 $ (271,557) $ 13,025 $ 42,206
Balance (in shares) at Dec. 27, 2015 38,423,000            
Net income       102,820   2,607 105,427
Other comprehensive income (loss)     (4,051)       (4,051)
Cash dividends paid   119   (27,898)     (27,779)
Exercise of stock options $ 3 7,056         $ 7,059
Exercise of stock options (in shares) 334,000           478,000
Tax effect of equity awards   (7)         $ (7)
Acquisition of Company common stock         (122,381)   (122,381)
Acquisition of Company common stock (in shares) (2,145,000)            
Stock-based compensation expense   10,123         10,123
Issuance of restricted stock $ 1 (2,975)     2,974    
Issuance of restricted stock (in shares) 58,000            
Change in redemption value of noncontrolling interests       567     567
Contributions from noncontrolling interests           690 690
Distributions to noncontrolling interests           (2,610) (2,610)
Other   (91)     648   557
Other (in shares) 13,000            
Balance at Dec. 25, 2016 $ 441 172,573 (5,887) 219,278 (390,316) 13,712 9,801
Balance (in shares) at Dec. 25, 2016 36,683,000            
Net income       102,292   2,038 104,330
Other comprehensive income (loss)     3,770       3,770
Cash dividends paid   136   (30,728)     (30,592)
Exercise of stock options $ 1 6,259         $ 6,260
Exercise of stock options (in shares) 147,000           147,000
Tax effect of equity awards   (2,428)         $ (2,428)
Acquisition of Company common stock         (209,586)   (209,586)
Acquisition of Company common stock (in shares) (2,960,000)            
Stock-based compensation expense   10,413         10,413
Issuance of restricted stock   (2,427)     2,427    
Issuance of restricted stock (in shares) 54,000            
Change in redemption value of noncontrolling interests       1,419     1,419
Contributions from noncontrolling interests           2,956 2,956
Distributions to noncontrolling interests           (2,949) (2,949)
Other   259   (10) 403   652
Other (in shares) 7,000            
Balance at Dec. 31, 2017 $ 442 184,785 (2,117) 292,251 (597,072) 15,757 (105,954)
Balance (in shares) at Dec. 31, 2017 33,931,000            
Cumulative effect of adoption of ASU 2014-09       (21,528)     (21,528)
Adjusted balance $ 442 184,785 (2,117) 270,723 (597,072) 15,757 (127,482)
Net income       1,646   1,874 3,520
Other comprehensive income (loss)     (571)       (571)
Adoption of ASU 2018-02     (455) 455      
Cash dividends paid   145   (28,944)     (28,799)
Exercise of stock options $ 1 2,698         $ 2,699
Exercise of stock options (in shares) 75,000           75,000
Tax effect of equity awards   (1,521)         $ (1,521)
Acquisition of Company common stock         (158,049)   (158,049)
Acquisition of Company common stock (in shares) (2,697,000)            
Stock-based compensation expense   9,936         9,936
Issuance of restricted stock   (3,005)     3,005    
Issuance of restricted stock (in shares) 56,000            
Distributions to noncontrolling interests           (2,406) (2,406)
Other   (54)   181 412   539
Other (in shares) 7,000            
Balance at Dec. 30, 2018 $ 443 $ 192,984 $ (3,143) $ 244,061 $ (751,704) $ 15,225 $ (302,134)
Balance (in shares) at Dec. 30, 2018 31,372,000